Cargando…

Human papillomavirus 16-specific cell-mediated immunity in children born to mothers with incident cervical intraepithelial neoplasia (CIN) and to those constantly HPV negative

OBJECTIVES: HPV infections are detected in sexually naive children. This has raised the question about the role of early HPV infections in either protecting or predisposing to further HPV infections. HPV16-specific cell-mediated immunity (CMI) was studied in 10 case-children born to mothers with an...

Descripción completa

Detalles Bibliográficos
Autores principales: Koskimaa, Hanna-Mari, Paaso, Anna, Welters, Marij J. P., Grénman, Seija, Syrjänen, Kari, van der Burg, Sjoerd H., Syrjänen, Stina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659171/
https://www.ncbi.nlm.nih.gov/pubmed/26608420
http://dx.doi.org/10.1186/s12967-015-0733-4
_version_ 1782402583986438144
author Koskimaa, Hanna-Mari
Paaso, Anna
Welters, Marij J. P.
Grénman, Seija
Syrjänen, Kari
van der Burg, Sjoerd H.
Syrjänen, Stina
author_facet Koskimaa, Hanna-Mari
Paaso, Anna
Welters, Marij J. P.
Grénman, Seija
Syrjänen, Kari
van der Burg, Sjoerd H.
Syrjänen, Stina
author_sort Koskimaa, Hanna-Mari
collection PubMed
description OBJECTIVES: HPV infections are detected in sexually naive children. This has raised the question about the role of early HPV infections in either protecting or predisposing to further HPV infections. HPV16-specific cell-mediated immunity (CMI) was studied in 10 case-children born to mothers with an incident cervical intraepithelial neoplasia (CIN) diagnosed during their 14-year follow-up (FU), and in 21 children born to mothers, who remained constantly HPV-negative (controls). The mean age of children was 12.3 years. METHODS: Peripheral blood mononuclear cells were isolated from blood and stimulated with peptide pools covering HPV16 E2, E6 and E7. Proliferation of lymphocytes, their secretion of cytokines, and the frequency of regulatory T-cells were determined. The results were correlated with the HPV status and analyzed in a nested case–control setting. RESULTS: All children, except two controls, displayed CMI against HPV16 E2, E6 and/or E7 peptides associated with type 1 and 2 cytokine secretion. Only two statistically significant differences were found in the nested case–control setting; (1) case-children had a higher TNF-α response to HPV16 E2 (p = 0.004) than controls and (2) controls had no response to HPV16 E7.2 peptide pool while 3/10 case-children had (p = 0.013). Totally, 50 and 57 % of the cases and controls, respectively, had HPV positive oral samples at some FU-visit. In addition, the children without any HPV antibodies before the age of 6 months showed proliferative responses of PBMC after HPV16 exposure more frequently than other children (p = 0.045). CONCLUSIONS: HPV16-specific CMI is common in young, sexually inexperienced children. This suggests that oral HPV infections occur frequently in children. Our results might also explain the previous findings that half of healthy adults demonstrate HPV-specific CMI irrespective of their partner/sexual status. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-015-0733-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4659171
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46591712015-11-26 Human papillomavirus 16-specific cell-mediated immunity in children born to mothers with incident cervical intraepithelial neoplasia (CIN) and to those constantly HPV negative Koskimaa, Hanna-Mari Paaso, Anna Welters, Marij J. P. Grénman, Seija Syrjänen, Kari van der Burg, Sjoerd H. Syrjänen, Stina J Transl Med Research OBJECTIVES: HPV infections are detected in sexually naive children. This has raised the question about the role of early HPV infections in either protecting or predisposing to further HPV infections. HPV16-specific cell-mediated immunity (CMI) was studied in 10 case-children born to mothers with an incident cervical intraepithelial neoplasia (CIN) diagnosed during their 14-year follow-up (FU), and in 21 children born to mothers, who remained constantly HPV-negative (controls). The mean age of children was 12.3 years. METHODS: Peripheral blood mononuclear cells were isolated from blood and stimulated with peptide pools covering HPV16 E2, E6 and E7. Proliferation of lymphocytes, their secretion of cytokines, and the frequency of regulatory T-cells were determined. The results were correlated with the HPV status and analyzed in a nested case–control setting. RESULTS: All children, except two controls, displayed CMI against HPV16 E2, E6 and/or E7 peptides associated with type 1 and 2 cytokine secretion. Only two statistically significant differences were found in the nested case–control setting; (1) case-children had a higher TNF-α response to HPV16 E2 (p = 0.004) than controls and (2) controls had no response to HPV16 E7.2 peptide pool while 3/10 case-children had (p = 0.013). Totally, 50 and 57 % of the cases and controls, respectively, had HPV positive oral samples at some FU-visit. In addition, the children without any HPV antibodies before the age of 6 months showed proliferative responses of PBMC after HPV16 exposure more frequently than other children (p = 0.045). CONCLUSIONS: HPV16-specific CMI is common in young, sexually inexperienced children. This suggests that oral HPV infections occur frequently in children. Our results might also explain the previous findings that half of healthy adults demonstrate HPV-specific CMI irrespective of their partner/sexual status. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-015-0733-4) contains supplementary material, which is available to authorized users. BioMed Central 2015-11-25 /pmc/articles/PMC4659171/ /pubmed/26608420 http://dx.doi.org/10.1186/s12967-015-0733-4 Text en © Koskimaa et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Koskimaa, Hanna-Mari
Paaso, Anna
Welters, Marij J. P.
Grénman, Seija
Syrjänen, Kari
van der Burg, Sjoerd H.
Syrjänen, Stina
Human papillomavirus 16-specific cell-mediated immunity in children born to mothers with incident cervical intraepithelial neoplasia (CIN) and to those constantly HPV negative
title Human papillomavirus 16-specific cell-mediated immunity in children born to mothers with incident cervical intraepithelial neoplasia (CIN) and to those constantly HPV negative
title_full Human papillomavirus 16-specific cell-mediated immunity in children born to mothers with incident cervical intraepithelial neoplasia (CIN) and to those constantly HPV negative
title_fullStr Human papillomavirus 16-specific cell-mediated immunity in children born to mothers with incident cervical intraepithelial neoplasia (CIN) and to those constantly HPV negative
title_full_unstemmed Human papillomavirus 16-specific cell-mediated immunity in children born to mothers with incident cervical intraepithelial neoplasia (CIN) and to those constantly HPV negative
title_short Human papillomavirus 16-specific cell-mediated immunity in children born to mothers with incident cervical intraepithelial neoplasia (CIN) and to those constantly HPV negative
title_sort human papillomavirus 16-specific cell-mediated immunity in children born to mothers with incident cervical intraepithelial neoplasia (cin) and to those constantly hpv negative
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659171/
https://www.ncbi.nlm.nih.gov/pubmed/26608420
http://dx.doi.org/10.1186/s12967-015-0733-4
work_keys_str_mv AT koskimaahannamari humanpapillomavirus16specificcellmediatedimmunityinchildrenborntomotherswithincidentcervicalintraepithelialneoplasiacinandtothoseconstantlyhpvnegative
AT paasoanna humanpapillomavirus16specificcellmediatedimmunityinchildrenborntomotherswithincidentcervicalintraepithelialneoplasiacinandtothoseconstantlyhpvnegative
AT weltersmarijjp humanpapillomavirus16specificcellmediatedimmunityinchildrenborntomotherswithincidentcervicalintraepithelialneoplasiacinandtothoseconstantlyhpvnegative
AT grenmanseija humanpapillomavirus16specificcellmediatedimmunityinchildrenborntomotherswithincidentcervicalintraepithelialneoplasiacinandtothoseconstantlyhpvnegative
AT syrjanenkari humanpapillomavirus16specificcellmediatedimmunityinchildrenborntomotherswithincidentcervicalintraepithelialneoplasiacinandtothoseconstantlyhpvnegative
AT vanderburgsjoerdh humanpapillomavirus16specificcellmediatedimmunityinchildrenborntomotherswithincidentcervicalintraepithelialneoplasiacinandtothoseconstantlyhpvnegative
AT syrjanenstina humanpapillomavirus16specificcellmediatedimmunityinchildrenborntomotherswithincidentcervicalintraepithelialneoplasiacinandtothoseconstantlyhpvnegative